Adial Pharmaceuticals, Inc

NASDAQADILW
At close
No trades
See on super-charts

Key stats

Market capitalization
10.044MUSD
Dividends yield (FY)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
−0.6887USD

About Adial Pharmaceuticals, Inc

ISIN
US00688A1144
CEO
Cary J. Claiborne
Headquarters
Charlottesville
Employees
18
Founded
2010

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.

Income Statement
Balance Sheet
Cash Flow
Earnings
Next:
‪0‬
Revenue
‪0‬

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more